Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Michael S. Clark, MD, PhD: The 5-HT1B Receptor: Behavioral Implications
1
x
$
30.00
Duloxetine in Military Posttraumatic Stress Disorder
1
x
$
30.00
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
1
x
$
30.00
Philip T. Ninan, MD: Pharmacokinetically Induced Benzodiazepine Withdrawal
1
x
$
30.00
Humberto Marin, MD: Special Issues in the Psychopharmacological Management of Hispanic Americans
1
x
$
30.00
Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults
1
x
$
30.00
View Cart
Checkout
Home
extended-release
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Page load link
Go to Top
